Medication-assisted treatment and comprehensive psychiatric care for opioid dependence including heroin and prescription opioids
Opioid use disorder is a severe, chronic medical condition characterized by continued use of opioid drugs despite serious harm and loss of control over use. Opioids include heroin (illicit), prescription painkillers (morphine, codeine, oxycodone, hydrocodone), and synthetic opioids (fentanyl, tramadol).
Opioids act on opioid receptors in the brain, spine, and gut, producing pain relief, euphoria, and sedation. Their powerful addictive potential results from both intense pleasurable effects and severe withdrawal symptoms, creating a cycle of dependence.
Opioid addiction is a highly treatable medical condition. Medication-assisted treatment combined with psychotherapy and behavioral support yields the best outcomes, with relapse rates significantly lower than detoxification alone.
Taking opioids in larger amounts or for longer than intended
Unsuccessful efforts to reduce or control opioid use
Powerful urges to use opioids despite negative consequences
Requiring increasingly higher doses to achieve desired effects
Reduced work/school performance, social withdrawal, poor self-care
Persistent use despite physical, psychological, or social problems
Opioid withdrawal is intensely uncomfortable and medically dangerous. While not typically fatal, withdrawal can lead to dangerous behaviors, medical complications, and high relapse rates. Medical management is essential.
Timeline: Symptoms typically resolve within 5-10 days, though protracted withdrawal (persistent mild symptoms) can last weeks. Medication-assisted treatment dramatically reduces withdrawal severity and discomfort.
Opioid overdose causes respiratory depression and can be fatal. Synthetic opioids like fentanyl are particularly dangerous. Naloxone (Narcan) can reverse overdose if administered quickly.
Injection drug use increases risk of HIV, Hepatitis B/C, bacterial endocarditis, and skin infections. Sharing equipment poses serious transmission risks.
Depression, anxiety, PTSD, and other mental health disorders frequently co-occur with opioid dependence and require integrated treatment.
Job loss, relationship breakdown, financial problems, legal issues from drug acquisition or related crimes, and homelessness are common consequences.
Dr. Sidharth Sood provides comprehensive medication-assisted treatment combining evidence-based medications with counseling and behavioral therapies:
A long-acting synthetic opioid that prevents withdrawal and reduces cravings.
A partial mu-opioid agonist with lower abuse potential and easier withdrawal.
An opioid antagonist that blocks euphoric effects and prevents relapse.
Medication is combined with comprehensive behavioral support:
Why MAT Works: Medication-assisted treatment addresses both the biological (medication suppresses withdrawal and cravings) and psychological (counseling and behavioral support) aspects of opioid dependence, resulting in significantly better outcomes than detoxification alone.
Success Rates: Studies consistently show 50-70% remain in treatment long-term on MAT, versus 5-10% without medication. Longer treatment duration predicts better outcomes.
Professional assessment is crucial for opioid use disorder
Previous overdose is major risk factor requiring immediate treatment
Medication-assisted treatment is more effective than detox alone
Depression, anxiety, or trauma require integrated treatment
Yes. Methadone and buprenorphine are FDA-approved, safe medications when properly prescribed and monitored. They prevent withdrawal, reduce cravings, and block euphoric effects. Decades of research support their safety and efficacy.
Duration varies. Some patients benefit from long-term maintenance (years to lifetime), while others successfully taper after achieving stable recovery. Treatment duration depends on individual factors, relapse history, and personal goals.
Methadone overdose is possible, especially when combined with other drugs. Buprenorphine has a "ceiling effect" making overdose less likely. Both carry lower overdose risk than heroin or prescription opioids.
Yes, methadone and buprenorphine may show on standard drug tests, though more specific testing can differentiate them. This should be disclosed to employers or legal systems. This is legitimate medical treatment.
This depends on the medication. Methadone at higher doses blocks euphoria. Buprenorphine's partial agonist effect produces mild euphoria at low doses. Naltrexone completely blocks euphoria. The goal is stability, not euphoria.
Professional medication-assisted treatment and psychiatric care for opioid dependence. Recovery is possible with expert guidance.